galactosyl-(1-3)galactose has been researched along with arginyl-glycyl-aspartic acid in 1 studies
Studies (galactosyl-(1-3)galactose) | Trials (galactosyl-(1-3)galactose) | Recent Studies (post-2010) (galactosyl-(1-3)galactose) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
493 | 3 | 100 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, CB; Dykhuizen, EC; Kiessling, LL; Mowery, P; Owen, RM | 1 |
1 other study(ies) available for galactosyl-(1-3)galactose and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Selective tumor cell targeting using low-affinity, multivalent interactions.
Topics: Antineoplastic Agents; Cell Line, Tumor; Complement System Proteins; Disaccharides; Doxorubicin; Drug Design; Humans; Integrin alphaVbeta3; Molecular Weight; Neoplasms; Oligopeptides | 2007 |